In vitro and in vivo evaluation of US-NCI compounds in human tumor xenografts.
Fiebig
H H
HH
Department of Internal Medicine, University of Freiburg, F.R.G.
Berger
D P
DP
Winterhalter
B R
BR
Plowman
J
J
D000818:Animals; D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic / Q000737:chemistry / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology*; D004354:Drug Screening Assays, Antitumor; D005260:Female; D006801:Humans; D051379:Mice; D008819:Mice, Nude; D009316:National Institutes of Health (U.S.); D009368:Neoplasm Transplantation; D010847:Picolines / Q000737:chemistry / Q000494:pharmacology; D011090:Polyenes / Q000737:chemistry / Q000494:pharmacology; D011719:Pyrazines / Q000737:chemistry / Q000494:pharmacology; D020123:Sirolimus; D013451:Sulfonic Acids / Q000737:chemistry / Q000494:pharmacology; D013729:Terpenes / Q000737:chemistry / Q000494:pharmacology; D014410:Tumor Stem Cell Assay; D014481:United States
D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D010847:Picolines; D011090:Polyenes; D011719:Pyrazines; D013451:Sulfonic Acids; D013729:Terpenes; C051397:pyrazine-2-diazohydroxide; C058388:penclomedine; C055925:anthrapyrazole; C052475:hepsulfam; C001470:4-ipomeanol; D020123:Sirolimus